Teiko
Our mission is to digitize the immune system.
About Teiko
Teiko is building the Artificial Immunologist. With 500M+ years in the making, the immune system is nature’s original fine-tuned model. We are building a foundational laboratory to digitize this system and reshape multi-billion dollar markets across clinical trials, oncology, autoimmune diagnostics, prenatal medicine, surgical recovery, and aging.
By capturing high-resolution immune snapshots, we give drug developers and doctors the decisive signal they need to predict whether a $200M+ clinical trial succeeds, whether a therapy will cause irreversible harm, or whether a patient will respond to a crucial drug. Through deep technical breakthroughs, we have cracked the key challenges that have held back immune profiling from achieving clinical-grade scale.
Today we power 30+ trials for Genentech, Recursion, iOnctura, Obsidian, and many more. Revenue has grown explosively because we solve critical problems that have bedeviled drug developers and doctors for years. Our interdisciplinary team brings together pioneers and experts in immunology, advanced diagnostics, and machine learning.
Open positions (2)
Company details
Funding
Total raised
$13.1M
Last stage
Series A
Investors
Founders
Ramji Srinivasan
Serial entrepreneur and Stanford alumnus. Previously co-founded and served as CEO of Counsyl, a women's health genetic screening company acquired by Myriad Genetics in 2018 for $375M. Holds a BS in Computer Science and MS in Financial Mathematics from Stanford.
LinkedInWhat happens next.
No applications, no recruiter spam. Just the intro.
Confirm the fit
A few questions to make sure this role is the right shape for you. Two minutes.
I pitch you to the company
I write the intro, send it to the founder, and handle the back-and-forth.
A meeting lands on your calendar
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.